Introduction of Caplacizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 Code History

Introduction of Iobenguane I-131 Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 5 Code History

Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Tagraxofusp-erzs Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 5 Code History

Introduction of Glofitamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Lifileucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of CD24Fc Immunomodulator into Peripheral Vein, Percutaneous Approach, New Technology Group 6 Code History